why choose us

First received: October 02, 2022

Clinical Trial: Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Febrile Neutropenia

Study Type: INTERVENTIONAL


Official Title: Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy at Risk for Developing Infections and/or Cytokine Release Syndrome

Brief Summary: IDION is currently seeking FDA approval for this device- the IDION iTempShield.It is a skin-safe, FDA complaint and non-invasive device that can read and monitor skin temperature.Having continuous temperature monitoring using the IDION iTempShield may provide early detection of a fever for patients with febrile neutropenia.Febrile neutropenic fever is common in patients receiving chemotherapy and can often indicate infection.The main potential benefit potenially experienced from participating in this study would…

Read more